Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions. Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients' demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
This report elaborates on the current development of the Ranibizumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis
Genentech
By Type:
Single-use prefilled syringe
Single-use glass vial
By Application:
Diabetic Macular Edema (DME)
Diabetic Retinopathy (DR)
mCNV
AMD
RVO
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Ranibizumab Market Overview 2018-2029
-
1.1 China Ranibizumab Industry Development Overview
-
1.2 China Ranibizumab Industry Development History
-
1.3 China Ranibizumab Industry Market Size (2018-2029)
-
1.4 China Ranibizumab Market Analysis by Type from Production Side
-
1.4.1 China Ranibizumab Production Volume, Production Value and Growth Rate of Single-use prefilled syringe (2018-2029)
-
1.4.2 China Ranibizumab Production Volume, Production Value and Growth Rate of Single-use glass vial (2018-2029)
-
1.5 China Ranibizumab Market Analysis by Application from Consumption End
-
1.5.1 China Ranibizumab Sales Volume, Sales Value and Growth Rate of Diabetic Macular Edema (DME) (2018-2029)
-
1.5.2 China Ranibizumab Sales Volume, Sales Value and Growth Rate of Diabetic Retinopathy (DR) (2018-2029)
-
1.5.3 China Ranibizumab Sales Volume, Sales Value and Growth Rate of mCNV (2018-2029)
-
1.5.4 China Ranibizumab Sales Volume, Sales Value and Growth Rate of AMD (2018-2029)
-
1.5.5 China Ranibizumab Sales Volume, Sales Value and Growth Rate of RVO (2018-2029)
-
1.6 China Ranibizumab Market Analysis by Region
-
1.6.1 North China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Ranibizumab Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Ranibizumab Market Size and Growth Rate from 2018-2029
Chapter 2 China Ranibizumab Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Ranibizumab Market Status and Competition at home and abroad in 2023
-
2.2.2 China Ranibizumab Market Status and Competition Analysis in 2023
-
2.2.3 China Ranibizumab Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Ranibizumab Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Ranibizumab Industry Development
Chapter 3 RanibizumabIndustry Chain Analysis
-
3.1 Ranibizumab Industry Chain
-
3.2 Ranibizumab Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Ranibizumab Market
-
3.3 Ranibizumab Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Ranibizumab Market
Chapter 4 China Ranibizumab Market, by Type
-
4.1 China Ranibizumab Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Ranibizumab Total Production Volume and Growth Rate from Production Side
-
4.5 China Ranibizumab Production Volume and Growth Rate, by Type
-
4.5.1 China Ranibizumab Production Volume and Growth Rate of Single-use prefilled syringe
-
4.5.2 China Ranibizumab Production Volume and Growth Rate of Single-use glass vial
Chapter 5 China Ranibizumab Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Ranibizumab Total Market Size and Growth Rate from Consumption End
-
5.5 China Ranibizumab Market Size and Growth Rate, by Application
-
5.5.1 China Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME)
-
5.5.2 China Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR)
-
5.5.3 China Ranibizumab Market Size and Growth Rate of mCNV
-
5.5.4 China Ranibizumab Market Size and Growth Rate of AMD
-
5.5.5 China Ranibizumab Market Size and Growth Rate of RVO
Chapter 6 China Ranibizumab Market, by Region
-
6.1 China Ranibizumab Production Volume and Production Value, by Region
-
6.2 China Ranibizumab Sales Volume and Sales Value, by Region
Chapter 7 North China Ranibizumab Market Analysis
-
7.1 North China Ranibizumab Market, by Type
-
7.2 North China Ranibizumab Market, by Application
Chapter 8 Central China Ranibizumab Market Analysis
-
8.1 Central China Ranibizumab Market, by Type
-
8.2 Central China Ranibizumab Market, by Application
Chapter 9 South China Ranibizumab Market Analysis
-
9.1 South China Ranibizumab Market, by Type
-
9.2 South China Ranibizumab Market, by Application
Chapter 10 East China Ranibizumab Market Analysis
-
10.1 East China Ranibizumab Market, by Type
-
10.2 East China Ranibizumab Market, by Application
Chapter 11 Northeast China Ranibizumab Market Analysis
-
11.1 Northeast China Ranibizumab Market, by Type
-
11.2 Northeast China Ranibizumab Market, by Application
Chapter 12 Southwest China Ranibizumab Market Analysis
-
12.1 Southwest China Ranibizumab Market, by Type
-
12.2 Southwest China Ranibizumab Market, by Application
Chapter 13 Northwest China Ranibizumab Market Analysis
-
13.1 Northwest China Ranibizumab Market, by Type
-
13.2 Northwest China Ranibizumab Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis
-
14.1.1 Novartis Company Profile
-
14.1.2 Novartis Ranibizumab Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Genentech
-
14.2.1 Genentech Company Profile
-
14.2.2 Genentech Ranibizumab Market Performance
-
14.2.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Ranibizumab Industry Research Conclusions
-
15.2 Ranibizumab Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Ranibizumab Industry Market Size (2018-2029)
-
Figure China Ranibizumab Production Volume, Production Value and Growth Rate of Single-use prefilled syringe (2018-2029)
-
Figure China Ranibizumab Production Volume, Production Value and Growth Rate of Single-use glass vial (2018-2029)
-
Figure China Ranibizumab Sales Volume, Sales Value and Growth Rate of Diabetic Macular Edema (DME) (2018-2029)
-
Figure China Ranibizumab Sales Volume, Sales Value and Growth Rate of Diabetic Retinopathy (DR) (2018-2029)
-
Figure China Ranibizumab Sales Volume, Sales Value and Growth Rate of mCNV (2018-2029)
-
Figure China Ranibizumab Sales Volume, Sales Value and Growth Rate of AMD (2018-2029)
-
Figure China Ranibizumab Sales Volume, Sales Value and Growth Rate of RVO (2018-2029)
-
Figure North China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure Central China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure South China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure East China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Ranibizumab Market Size and Growth Rate from 2018-2029
-
Figure Ranibizumab Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Ranibizumab Market Share by Type in 2018
-
Figure China Ranibizumab Market Share by Type in 2023
-
Figure China Ranibizumab Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Ranibizumab Production Volume and Growth Rate of Single-use prefilled syringe (2018-2023)
-
Figure China Ranibizumab Production Volume and Growth Rate of Single-use glass vial (2018-2023)
-
Figure China Ranibizumab Market Share by Application in 2018
-
Figure China Ranibizumab Market Share by Application in 2023
-
Figure China Ranibizumab Total Market Size and Growth Rate from Consumption End
-
Figure China Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) (2018-2023)
-
Figure China Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) (2018-2023)
-
Figure China Ranibizumab Market Size and Growth Rate of mCNV (2018-2023)
-
Figure China Ranibizumab Market Size and Growth Rate of AMD (2018-2023)
-
Figure China Ranibizumab Market Size and Growth Rate of RVO (2018-2023)
-
Table China Ranibizumab Production Volume by Region (2018-2023)
-
Table China Ranibizumab Production Volume Share by Region (2018-2023)
-
Figure China Ranibizumab Production Volume Share by Region (2018-2023)
-
Table China Ranibizumab Production Value by Region (2018-2023)
-
Table China Ranibizumab Production Value Share by Region (2018-2023)
-
Figure China Ranibizumab Production Value Share by Region (2018-2023)
-
Table China Ranibizumab Sales Volume by Region (2018-2023)
-
Table China Ranibizumab Sales Volume Share by Region (2018-2023)
-
Figure China Ranibizumab Sales Volume Share by Region (2018-2023)
-
Table China Ranibizumab Sales Value by Region (2018-2023)
-
Table China Ranibizumab Sales Value Share by Region (2018-2023)
-
Figure China Ranibizumab Sales Value Share by Region (2018-2023)
-
Table North China Ranibizumab Production Volume by Type (2018-2023)
-
Table North China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure North China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table North China Ranibizumab Sales Volume by Application (2018-2023)
-
Table North China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure North China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table Central China Ranibizumab Production Volume by Type (2018-2023)
-
Table Central China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure Central China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table Central China Ranibizumab Sales Volume by Application (2018-2023)
-
Table Central China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure Central China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table South China Ranibizumab Production Volume by Type (2018-2023)
-
Table South China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure South China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table South China Ranibizumab Sales Volume by Application (2018-2023)
-
Table South China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure South China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table East China Ranibizumab Production Volume by Type (2018-2023)
-
Table East China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure East China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table East China Ranibizumab Sales Volume by Application (2018-2023)
-
Table East China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure East China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table Northeast China Ranibizumab Production Volume by Type (2018-2023)
-
Table Northeast China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure Northeast China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table Northeast China Ranibizumab Sales Volume by Application (2018-2023)
-
Table Northeast China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table Southwest China Ranibizumab Production Volume by Type (2018-2023)
-
Table Southwest China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure Southwest China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table Southwest China Ranibizumab Sales Volume by Application (2018-2023)
-
Table Southwest China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table Northwest China Ranibizumab Production Volume by Type (2018-2023)
-
Table Northwest China Ranibizumab Production Volume Share by Type (2018-2023)
-
Figure Northwest China Ranibizumab Production Volume Share by Type (2018-2023)
-
Table Northwest China Ranibizumab Sales Volume by Application (2018-2023)
-
Table Northwest China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Ranibizumab Sales Volume Share by Application (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Ranibizumab Revenue, Price and Gross (2018-2023)
-
Table Genentech Company Profile
-
Table Genentech Ranibizumab Revenue, Price and Gross (2018-2023)
-
